Flanagan; Jack Urquhart

Patent Applications and Registrations

Patent applications and USPTO patent grants for Flanagan; Jack Urquhart.The latest application filed is for "tricyclic heterocyclic derivatives and uses thereof".

Company Profile

3.9.8

Flanagan; Jack Urquhart - Auckland NZ
Flanagan; Jack Urquhart - North Shore AU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tricyclic heterocyclic derivatives and uses thereof Grant 11,028,064 - Gamage , et al. June 8, 2	2021-06-08
Tricyclic Heterocyclic Derivatives And Uses Thereof App 20190276423 - GAMAGE; Swarnalatha Akuratiya ; et al.	2019-09-12
Bacterial nitroreductase enzymes and methods relating thereto Grant 10,357,577 - Guise , et al. July 23, 2	2019-07-23
Haematopoietic-prostaglandin D2 synthase inhibitors Grant 9,199,976 - Smythe , et al. December 1, 2	2015-12-01
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 9,108,980 - Rewcastle , et al. August 18, 2	2015-08-18
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20150038486 - Rewcastle; Gordon William ; et al.	2015-02-05
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 8,772,287 - Rewcastle , et al. July 8, 2	2014-07-08
Bacterial Nitroreductase Enzymes And Methods Relating Thereto App 20130295011 - Guise; Christopher Paul ; et al.	2013-11-07
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20130289016 - Rewcastle; Gordon William ; et al.	2013-10-31
Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy Grant 8,461,158 - Rewcastle , et al. June 11, 2	2013-06-11
Haematopoietic-prostaglandin D2 Synthase Inhibitors App 20130137684 - Smythe; Mark Leslie ; et al.	2013-05-30
Pyrimidinyl And 1,3,5-triazinyl Benzimidazole Sulfonamides And Their Use In Cancer Therapy App 20100249099 - Rewcastle; Gordon William ; et al.	2010-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.